← Leaderboards
Jesse Joshua Smith
Sloan-Kettering Inst Can Research
$3,709,431
Attributed
$3,709,431
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $704.4K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,709,431 · 1
By mechanism
R37$3,709,431 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Nikolaus Schultz$13,183,744
- Ethan Cerami$14,256,482
- Nicholas D Socci$8,843,502
- Sohrab P Shah$4,881,319
- Andrea Cercek$4,410,417
Others in their field
Other Emerging Leaders on “Histology”
- John Freymann · Leidos Biomedical Research, Inc.$14,011,208
- Thomas Steinbach · Experimental Pathology Laboratories$11,153,684
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,153,043
- Shadi Dayeh · University Of California, San Diego$9,482,559
- Gabriel Nestor Sanchez · Enspectra Health, Inc.$7,941,485
Research focus
HistologyEffective TherapyFlexibilityGenomicsDiagnosisBiobankEnvironmentComplex3-DimensionalGenitourinary SystemAffectCbioportalCell Culture TechniquesCell LineAnatomyChemotherapyChemotherapy And/Or RadiationBiologyClinically RelevantCollectionColon Cancer Cell LineGene ExpressionCancer PatientImplant
Grant awards (9)
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$465,168
R37 · FY2025 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$80,454
R37 · FY2025 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$580,684
R37 · FY2024 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$45,002
R37 · FY2024 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$599,022
R37 · FY2023 · CA · contact PI
Diversity Supplement to Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$105,363
R37 · FY2023 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$611,246
R37 · FY2022 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$611,246
R37 · FY2021 · CA · contact PI
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient$611,246
R37 · FY2020 · CA · contact PI